Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Peter G, Shields"'
Autor:
Thomas R. Valentine, Carolyn J. Presley, David P. Carbone, Peter G. Shields, Barbara L. Andersen
Publikováno v:
Health Psychol
Of all cancers, advanced nonsmall cell lung cancer (NSCLC) is associated with the highest burden on mental and physical health-related quality of life (HRQoL). Patients' subjective beliefs about their cancer (i.e., illness perceptions) may influence
Autor:
Kevin L. Ying, Theodore M. Brasky, Jo L. Freudenheim, Joseph P. McElroy, Quentin A. Nickerson, Min-Ae Song, Daniel Y. Weng, Mark D. Wewers, Noah B. Whiteman, Ewy A. Mathe, Peter G. Shields
Publikováno v:
Cancer Prev Res (Phila)
The microbiome has increasingly been linked to cancer. Little is known about the lung and oral cavity microbiomes in smokers, and even less for electronic cigarette (EC) users, compared with never-smokers. In a cross-sectional study (n = 28) of smoke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d9ca25c62f3dec7a72197dec43e649
https://europepmc.org/articles/PMC9256774/
https://europepmc.org/articles/PMC9256774/
Autor:
K. Michael Cummings, Peter G. Shields, Micah L. Berman, David L. Ashley, Vaughan W. Rees, Warren K. Bickel, Dana M. Carroll, Xianghua Luo, Irina Stepanov, Richard J O'Connor, Maansi Bansal-Travers, Dorothy K. Hatsukami
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Relationships between cigarette filter ventilation levels, biomarkers of exposure (BOE) and potential harm (BOPH), and harm perceptions were examined. Methods: Filter ventilation levels in cigarette brands were merged with Wave 1 (2013–
Autor:
Yizhen Guo, Lai Wei, Sandip H. Patel, Gabrielle Lopez, Madison Grogan, Mingjia Li, Tyler Haddad, Andrew Johns, Latha P. Ganesan, Yiping Yang, Daniel J. Spakowicz, Peter G. Shields, Kai He, Erin M. Bertino, Gregory A. Otterson, David P. Carbone, Carolyn Presley, Samuel K. Kulp, Thomas A. Mace, Christopher C. Coss, Mitch A. Phelps, Dwight H. Owen
Publikováno v:
Clin Lung Cancer
MICROABSTRACT: Serum albumin in cancer patients is associated with clinical outcomes. In a single-center retrospective study of 210 advanced NSCLC patients receiving immune checkpoint inhibitor (ICI) with or without chemotherapy as first-line therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be19bfce21a04ebb6945272592627ee6
https://europepmc.org/articles/PMC9149057/
https://europepmc.org/articles/PMC9149057/
Autor:
Carolyn J Presley, Peter G. Shields, Barbara L. Andersen, Rachel M. Smith, David P. Carbone, Guy N. Brock, Joseph P. McElroy
Publikováno v:
Psychosom Med
OBJECTIVE Lung cancer remains the number one cause of cancer-related mortality worldwide, but less known is that lung cancer patients are among the most psychologically disabled of all cancer groups. Patients with stage-IV non-small cell lung cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0047ca1d30a8ba30cd8f3eca10cb0bee
https://europepmc.org/articles/PMC8831460/
https://europepmc.org/articles/PMC8831460/
Autor:
Irina Stepanov, Dana M. Carroll, Peter G. Shields, Katelyn M. Tessier, Dorothy K. Hatsukami, Xianghua Luo, Richard J O'Connor, Vaughan W. Rees, K. Michael Cummings, Sarah A. Reisinger
Publikováno v:
Tob Control
BackgroundWhile evidence demonstrates that the industry’s marketing of cigarettes with higher filter ventilation (FV) misleads adults about their health risks, there is no research on the relationships between FV, risk perceptions and smoking traje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f3c7841d9d916ea2da06a0cbe39442
https://europepmc.org/articles/PMC9160200/
https://europepmc.org/articles/PMC9160200/
Autor:
Peter G. Shields, David P. Carbone, Songzhu Zhao, Madison Grogan, Kai He, Daniel Spakowicz, Abdul Miah, Sandip H. Patel, Lai Wei, Mingjia Li, Erin M. Bertino, Dwight H. Owen, Gregory A. Otterson, Carolyn J Presley, Andrew Johns, Marium Husain
Publikováno v:
Cancer Immunol Immunother
BACKGROUND: Checkpoint inhibitor pneumonitis (CIP) is an immune related adverse event that may complicate treatment with immune checkpoint inhibitors (ICI) and can cause significant morbidity. We sought to identify predictors for the development of C
Autor:
Sarah A. Reisinger, Kevin L. Ying, Quentin A. Nickerson, Mark D. Wewers, Jo L. Freudenheim, Ewy Mathé, Peter G. Shields, Theodore M. Brasky, Min-Ae Song, Daniel Y. Weng, Dominic J. Smiraglia, Joseph P. McElroy
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Nicotine-containing electronic cigarette (e-cig) use has become widespread. However, understanding the biological impact of e-cigs compared with smoking on the lung is needed. There are major gaps in knowledge for chronic effects and for
Autor:
Gregory A. Otterson, Peter G. Shields, Thomas Edd, Miguel A. Villalona-Calero, Dwight H. Owen, Lai Wei, Erin M. Bertino, Kai He, David P. Carbone
Publikováno v:
Clinical lung cancer
Immunotherapy is a mainstay of treatment for nonesmall-cell lung cancer. Serious immune-related adverse events (irAEs) occur; however, their effect on survival is unclear, and no defined risks factors have been elucidated. In the present study, we fo
Autor:
Allison N. Tegge, Jeffrey S. Stein, Roberta Freitas-Lemos, Peter G. Shields, Dorothy K. Hatsukami, Warren K. Bickel, William B. DeHart, Sarah A. Reisinger
Publikováno v:
Addict Behav
Objectives Regulating filter ventilation will change the relative reinforcing value of products resulting in nicotine/tobacco users facing the explore/exploit dilemma (ie, choice between unfamiliar and familiar options). This study examined the effec